Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Open accessThe DOI matches its Crossref record; 148 of the 149 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Multifactorial treatment is necessary to improve long-term outcomes as stated in treatment guidelines [1,5,6].”
The cited source says what the claim attributes to it.
In the citing paper
“Type 2 diabetes is a complex disease [1,2] with an increasing prevalence worldwide [3,4].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1998) · The Lancet · doi:10.1016/s0140-6736(98)07019-6 · Cited by 20,023 · cited 7×
“In the UK Prospective Diabetes Study (UKPDS) [30, 31], patients with newly diagnosed type 2 diabetes were randomised to two treatment policies.”
BackgroundInfluentialCrossing the Quality Chasm: A New Health System for the 21st Century
Baker, A. (2001) · BMJ · doi:10.1136/bmj.323.7322.1192 · Cited by 10,736
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059 · cited 1×
“It is well established that the risk of microvascular and macrovascular complications is related to glycaemia, as measured by HbA1c; this remains a major focus of therapy [29].”
BackgroundTurner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
(1998) · The Lancet · doi:10.1016/s0140-6736(98)07037-8 · Cited by 8,247 · cited 2×
“By contrast, substantially fewer metformin-treated patients experienced myocardial infarction, diabetes-related and all-cause mortality [32], despite a mean HbA1c only 0.”
BackgroundEffects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751 · cited 1×
“The UKPDS 10‐year follow-up demonstrated that the relative benefit of having been in the intensive management policy group was maintained over a decade, resulting in the emergence of statistically significant benefits on cardiovascular disease (CVD) endpoints and total mortality in those initially assigned to sulfonyl…”
BackgroundSelf-citationIntensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397 · cited 1×
“Modified-Release Controlled Evaluation [ADVANCE] [35], Veterans Affairs Diabetes Trial [VADT] [36]) reported the effects of two levels of glycaemic control on cardiovascular”
BackgroundDormandy, J. A., Charbonnel, B., Eckland, D. J., Erdmann, E., Massi-Benedetti, M., Moules, I. K., Skene, A. M., Tan, M. H., Lefèbvre, P. J., Murray, G. D., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67528-9 · Cited by 4,129 · cited 3×
“It may therefore also be considered, unless heart failure is present [60].”
Background
Cited by
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,655
Mancia, G., Fagard, R., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., et al. (2013) · Journal of Hypertension · doi:10.1097/01.hjh.0000431740.32696.cc · Cited by 5,655
Kernan, W. N., Ovbiagele, B., Black, H. R., Bravata, D. M., Chimowitz, M. I., Ezekowitz, M. D., Fang, M. C., Fisher, M., Furie, K. L., Heck, D. V., et al. (2014) · Stroke · doi:10.1161/str.0000000000000024 · Cited by 5,170
“apply a patient-centered approach to selection of agents after metformin in patients with type 2 DM.(136) In this manner, the”
MethodInfluentialCosentino, F., Grant, P. J., Aboyans, V., Bailey, C. J., Ceriello, A., Delgado, V., Federici, M., Filippatos, G., Grobbee, D. E., Hansen, T. B., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz486 · Cited by 4,763
Standards of medical care in diabetes—2013
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s011 · Cited by 4,369
Metadata
- Authors
- Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R.
- Affiliations
- Yale New Haven Hospital (US)
- Park Nicollet Clinic (US)
- University of North Carolina at Chapel Hill (US)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- University of Pisa (IT)
- Diabeteszentrum Bad Lauterberg (DE)
- University of Southern California (US)
- Thomas Jefferson University (US)
- Churchill Hospital (GB)
- Corresponding author
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 2012-04-20
- Volume
- 55
- Issue
- 6
- Pages
- 1577-1596
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2111876001
- Cited by
- 3,919
- References
- 149
- Citations by year
- 2026: 7 · 2025: 16 · 2024: 31 · 2023: 32 · 2022: 43 · 2021: 121 · 2020: 160 · 2019: 192 · 2018: 279 · 2017: 375 · 2016: 483 · 2015: 627 · 2014: 776 · 2013: 595 · 2012: 176
- FWCI
- 558.20
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- American Diabetes Association
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- Amylin Pharmaceuticals
- AstraZeneca
- GlaxoSmithKline
- Sanofi
- Yale University
- University of Southern California
- University of Miami
- Wayne State University
- F. Hoffmann-La Roche
- Leona M. and Harry B. Helmsley Charitable Trust
- Georgetown University
- Case Western Reserve University
- School of Medicine, Case Western Reserve University
- MedStar Health Research Institute
- Intarcia Therapeutics
- Halozyme
- Dexcom
- National Institute for Health and Care Research (NF-SI-0508-10272)
- University of Sydney
- University of Melbourne
- Vrije Universiteit Amsterdam
- University of Toronto
- Novo Nordisk
- European Association for the Study of Diabetes
- Université de Nantes
- Servier
- University of Ioannina
- National Institutes of Health
- University of Illinois at Urbana-Champaign
- School of Medicine, University of Kansas
- Health Science Center, University of Tennessee
- Leonard M. Miller School of Medicine
- Novartis Pharma
- Abbott Diabetes Care
- Leonard M. Miller School of Medicine, University of Miami
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- type 2 diabetes, hyperglycemia management, glycemic control, patient-centered care, treatment guidelines, tight glycemic control, macrovascular complications
- MeSH terms
- Diabetes Mellitus, Type 2, Europe, Humans, Hyperglycemia, Hypoglycemic Agents, Societies, Medical, United States, Disease Management
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). https://app.cochat.ai/papers/10.1007/s00125-012-2534-0
- The paper
- Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012). Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. https://doi.org/10.1007/s00125-012-2534-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.